RT Journal Article
SR Electronic
T1 Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003188
DO 10.1136/jitc-2021-003188
VO 9
IS 8
A1 Mandalá, Mario
A1 Larkin, James
A1 Ascierto, Paolo A
A1 Del Vecchio, Michele
A1 Gogas, Helen
A1 Cowey, C Lance
A1 Arance, Ana
A1 Dalle, Stéphane
A1 Schenker, Michael
A1 Grob, Jean-Jacques
A1 Chiarion-Sileni, Vanna
A1 Marquez-Rodas, Ivan
A1 Butler, Marcus O
A1 Di Giacomo, Anna Maria
A1 Lutzky, Jose
A1 De La Cruz-Merino, Luis
A1 Atkinson, Victoria
A1 Arenberger, Petr
A1 Hill, Andrew
A1 Fecher, Leslie
A1 Millward, Michael
A1 Khushalani, Nikhil I
A1 de Pril, Veerle
A1 Lobo, Maurice
A1 Weber, Jeffrey
YR 2021
UL http://jitc.bmj.com/content/9/8/e003188.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.